SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 73 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $27,000 | -18.2% | 3,584 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $33,000 | +73.7% | 3,584 | 0.0% | 0.00% | – |
| Q1 2019 | $19,000 | 0.0% | 3,584 | -16.3% | 0.00% | -100.0% |
| Q4 2018 | $19,000 | -94.3% | 4,284 | -91.0% | 0.00% | -88.9% |
| Q2 2018 | $335,000 | -48.0% | 47,656 | +5.3% | 0.01% | -47.1% |
| Q1 2018 | $644,000 | +62.2% | 45,276 | 0.0% | 0.02% | +54.5% |
| Q4 2017 | $397,000 | -32.5% | 45,276 | -10.0% | 0.01% | -35.3% |
| Q3 2017 | $588,000 | -10.6% | 50,288 | +6.7% | 0.02% | -15.0% |
| Q2 2017 | $658,000 | +68.7% | 47,124 | +65.8% | 0.02% | +66.7% |
| Q1 2017 | $390,000 | +91.2% | 28,420 | 0.0% | 0.01% | +71.4% |
| Q4 2016 | $204,000 | – | 28,420 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,932,800 | $33,592,000 | 10.90% |
| Aisling Capital Management LP | 1,025,000 | $17,815,000 | 9.61% |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $55,536,000 | 4.73% |
| Paradigm Biocapital Advisors LP | 701,356 | $12,190,000 | 3.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,277,413 | $22,201,000 | 3.14% |
| Nantahala Capital Management | 2,692,303 | $46,792,000 | 2.07% |
| Avidity Partners Management LP | 4,823,400 | $83,831,000 | 1.75% |
| DAFNA Capital Management LLC | 371,987 | $6,465,000 | 1.68% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,582,000 | 1.67% |
| BVF INC/IL | 2,394,714 | $41,620,000 | 1.66% |